GL1X · GenesisL1 explorer

MolNFT v1 · #77208 · protein

CDK2 in complex with inhibitor kvr-1-9

3R7V · Cyclin-dependent kinase 2: “CDK2 in complex with inhibitor kvr-1-9”. X-ray diffraction, 1 ligand (Z02), 2 pockets (best druggability 0.76). MolNFT v1 #77208 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3R7V
Type
protein
Length
294 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclin-dependent kinase 2
EC
2.7.11.22
UniProt
P24941
Ligands
Z02
Pockets
2 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclin-dependent kinase 2 (EC 2.7.11.22)protein29434% helix, 15% strandP24941

Ligands and binding sites

  • Z02 · 5-nitro-2-[(pyridin-2-ylmethyl)amino]benzamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14680.760.8466Z02
2520.340.7814empty

Compared structures

  • 3R7V · CDK2 in complex with inhibitor KVR-1-9 · the same entry in another collection · chain A against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.